Roche
The role involves designing and executing in‑vitro experiments with complex cellular models to assess the efficacy and safety of novel therapeutic candidates for cardiovascular and metabolic diseases. The candidate will work in Roche’s pRED Cardiovascular & Metabolism, Immunology unit in Basel, collaborating with cross‑functional teams and reporting findings in high‑quality reports and presentations.
Headquarters
Basel, Basel-Stadt, Switzerland
Company Size
10001+ employees
Founded
1896
As a pioneer in healthcare, we have been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Roche.
Roche didn’t post a salary, so this is our estimate from similar listings.
Right around the average for this role
Roche Breast-Cancer Drug Combination Misses Target in Study
3 days ago
Lilly pledges $500M to South Korea biopharma industry, following Roche’s lead
1 day ago
Thesis work, 60 credits – Establishing In Vitro Models of Mitochondrial Dysfunction in Acute Kidney Injury for Preclinical Drug Discovery
AstraZeneca
Postdoctoral Research Scientist
Columbia University
Associate Scientist to Scientist, in vitro Biology
Structure Therapeutics
TEMP - Scientist, Immunology
Neurocrine Biosciences
Research Technician
University of North Carolina System
PRN Research Associate - Nutrition and Experimental Metabolism Lab
Saint Louis University